BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6374276)

  • 1. [Demonstration of circulating CEA or CEA-like antigens and immunoglobulin G containing immune complexes in colorectal carcinoma].
    Pompecki R
    Klin Wochenschr; 1984 Apr; 62(7):307-14. PubMed ID: 6374276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEA-containing immune complexes in sera of patients with colorectal and breast cancer--analysis of complexed immunoglobulin classes.
    Fuchs C; Krapf F; Kern P; Hoferichter S; Jäger W; Kalden JR
    Cancer Immunol Immunother; 1988; 26(2):180-4. PubMed ID: 3282655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer.
    Chester KA; Begent RH
    Clin Exp Immunol; 1984 Dec; 58(3):685-93. PubMed ID: 6509799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of CEA in colorectal carcinoma].
    Shimoyama T; Fukuda Y; Itoh S; Shimizu T; Kawaguchi A; Mori M; Ishii T; Miura T; Tomita M
    Gan No Rinsho; 1985 May; 31(6 Suppl):648-54. PubMed ID: 3897618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal carcinoma. Evidence for circulating CEA-anti-CEA complexes.
    Mavligit GM; Stuckey S
    Cancer; 1983 Jul; 52(1):146-9. PubMed ID: 6850537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum total gangliosides and TA90-IC levels: novel immunologic markers in colorectal cancer.
    Perez CA; Ravindranath MH; Gupta RK; Tollenaar RA; van de Velde CJ; Wood TF; Soh D; Morton DL; Bilchik AJ
    Cancer J; 2002; 8(1):55-61. PubMed ID: 11898807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon-specific antigen-p (CSAp). I. Initial clinical evaluation as a marker for colorectal cancer.
    Pant KD; Shochat D; Nelson MO; Goldenberg DM
    Cancer; 1982 Sep; 50(5):919-26. PubMed ID: 6178498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma.
    Boey J; Cheung HC; Lai CK; Wong J
    World J Surg; 1984 Jun; 8(3):279-86. PubMed ID: 6464483
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoreactive carcinoembryonic antigen [CEA] levels in feces from colorectal cancer patients.
    Kitsukawa Y
    Jpn J Surg; 1979 Jun; 9(2):102-9. PubMed ID: 449127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of adenocarcinomas of the colorectum with low levels of preoperative plasma carcinoembryonic antigen (CEA).
    Jubert AV; Talbott TM; Maycroft TM
    Cancer; 1978 Aug; 42(2):635-9. PubMed ID: 679156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of CEA in postoperative monitoring of colorectal cancers].
    Cossu F; Fodde M; Ledda P; Pisano G; Rombi GP; Scintu F; Tuveri A
    Minerva Med; 1984 Oct; 75(40):2373-80. PubMed ID: 6504398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of anti-carcinoembryonic antigen (CEA), specific immunoglobulins and their use in immunocytochemical and enzyme-immunoassays (ELISA).
    Niculescu F; Rus HG; Ionescu D; Maican A; Petcovici M; Malide D; Răhăian R
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):227-35. PubMed ID: 2519633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interest and limits of estimation of the carcinoembryonic antigen in colonic and rectal (author's transl)].
    Arnaud JP; Simon P; Ollier JC; Koehl C; Adloff M
    J Chir (Paris); 1979 Nov; 116(11):633-6. PubMed ID: 555768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen (CEA) monitoring of radiation therapy for colorectal cancer.
    Sugarbaker PH; Bloomer WD; Corbett ED; Chaffey JT
    AJR Am J Roentgenol; 1976 Oct; 127(4):641-4. PubMed ID: 970537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usefulness and limitations of CEA assay in the management of colorectal cancer.
    Tomoda H; Furusawa M
    Jpn J Surg; 1981 Jan; 11(1):33-8. PubMed ID: 7311186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes in patients following clinically curative resection of colorectal cancer.
    Steele G; Sonis S; Stelos P; Rittgers R; Zamcheck N; Finn D; Maltz J; Mayer R; Lokich J; Wilson RE
    Surgery; 1978 Jun; 83(6):648-54. PubMed ID: 205963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer.
    Armitage NC; Davidson A; Tsikos D; Wood CB
    Clin Oncol; 1984 Jun; 10(2):141-7. PubMed ID: 6375928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of carcinoembryonic antigen (CEA) by means of the immunoperoxidase technique in paraffin-embedded specimens of tumour tissues.
    Heidl G
    Exp Pathol; 1982; 21(2):79-88. PubMed ID: 6807709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
    Yu BM
    Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.
    Kuusela P; Jalanko H; Roberts P; Sipponen P; Mecklin JP; Pitkänen R; Mäkelä O
    Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.